Ursolic Acid Suppresses Colorectal Cancer Through Autophagy–Lysosomal Degradation of β-Catenin
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136210 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Chung-Ming Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Ming Chuan University, Taoyuan 33348, Taiwan. Hauptthemen laut MEDLINE: Autophagy, Triterpenes, beta Catenin, Colorectal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Medical University , Taiwan, China Medical University Hospital, Taiwan, China Medical University.
Abstract (Originalsprache)
Colorectal cancer remains a leading malignancy. As the aberrant activation of Wnt/β-catenin signaling causes colorectal cancer, Wnt/β-catenin signaling inhibitors are potential candidates for colorectal cancer treatment. Our drug screening platform identified ursolic acid (UA), a triterpenoid with various biological activities, as a potential anticancer drug because it inhibits the T-cell factor (TCF)/β-catenin-mediated transcriptional activity. Here, we discovered that UA inhibited Wnt signaling by reducing the Wnt reporter activity and Wnt target gene expression, leading to a delay in cell cycle progression and the suppression of cell proliferation. Stepwise epistatic analyses suggested that UA functions on β-catenin protein stability in Wnt signaling. Further studies revealed that UA reduced β-catenin protein levels by Western blotting and immunofluorescent staining and induced autophagy by microtubule-associated protein 1 light chain 3 beta (LC3B) punctate staining. The cotreatment with UA and the autophagy inhibitors chloroquine and wortmannin recovered the β-catenin protein levels. Therefore, UA was confirmed to induce β-catenin degradation by the autophagy–lysosomal degradation system through inhibition in the phosphatidylinositol 3-kinase (PI3K)/Ak strain transforming (protein kinase B; AKT)/mammalian target of rapamycin (mTOR) signaling pathway. Our results not only highlight the potential of UA in Wnt-driven colorectal cancer therapy but also provide a workable Wnt signaling termination approach for the treatment of other Wnt-related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Ming Chuan University, Taoyuan 33348, Taiwan.
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan.
- Division of Plastic and Reconstructive Surgery, Department of Surgery, China Medical University Hospital, Taichung 40402, Taiwan.
ORCID-Profile: Chung-Ming Lin
Förderung
- China Medical University , Taiwan
- China Medical University Hospital, Taiwan
- China Medical University
- China Medical University Hospital
Zitieren
APA
Lin, C. M., Chao, M. C., Chen, H. H., & Chen, H. J. (2025). Ursolic Acid Suppresses Colorectal Cancer Through Autophagy–Lysosomal Degradation of β-Catenin. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136210
Vancouver
Lin CM, Chao MC, Chen HH, Chen HJ. Ursolic Acid Suppresses Colorectal Cancer Through Autophagy–Lysosomal Degradation of β-Catenin. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136210
BibTeX
@article{Lin2025,
author = {Lin, Chung-Ming and Chao, Min-Chih and Chen, Hsin-Han and Chen, Hui-Jye},
title = {Ursolic Acid Suppresses Colorectal Cancer Through Autophagy–Lysosomal Degradation of β-Catenin},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136210}
}
EUVIMED